EVIDENCE FOR SPECIFIC AUTOIMMUNITY AGAINST SYMPATHETIC AND PARASYMPATHETIC NERVOUS TISSUES IN TYPE-1 DIABETES-MELLITUS AND THE RELATION TO CARDIAC AUTONOMIC DYSFUNCTION
D. Muhrbecker et al., EVIDENCE FOR SPECIFIC AUTOIMMUNITY AGAINST SYMPATHETIC AND PARASYMPATHETIC NERVOUS TISSUES IN TYPE-1 DIABETES-MELLITUS AND THE RELATION TO CARDIAC AUTONOMIC DYSFUNCTION, Diabetic medicine, 15(6), 1998, pp. 467-472
There is growing evidence for the involvement of immunological factors
in the pathogenesis of cardiac autonomic dysfunction in Type 1 diabet
es mellitus (DM). To evaluate the presence of autoantibodies against a
utonomic nervous tissues and their relationship with tests of autonomi
c function, 64 newly diagnosed and 142 long duration Type 1 DM patient
s were investigated for sympathetic and parasympathetic ganglia (CF-SG
and CF-PSG) autoantibodies with a complement-fixing indirect immunofl
uorescence technique. Five cardiac reflex tests were performed to asse
ss autonomic function. Fifty-seven patients with neurological diseases
other than diabetic neuropathy and 131 healthy control subjects were
also tested for CF-SG and CF-PSG autoantibodies. CF-SG autoantibodies
were observed in 47 (23%) and CF-PSG autoantibodies in 21 (10%) of 206
Type 1 DM patients (p < 0.001). In contrast, these autoantibodies wer
e detected in 3 (5%) and 1 (2%) of patients with non-diabetic neurolog
ical diseases and 3 (2%) and 4 (3%) of control subjects (p < 0.01, p <
0.05, p < 0.0001, p < 0.05 vs Type 1 DM patients). All except two Typ
e 1 DM patients with CF-PSG autoantibodies also presented with CF-SG a
utoantibodies. In diabetic patients with long duration, CF-SG autoanti
bodies were more frequent in patients with ECG-based cardiac autonomic
neuropathy (CAN; greater than or equal to 2 of 5 cardiac reflex tests
abnormal) compared to patients without CAN although this did not reac
h statistical significance (29% vs 17%, p = 0.06). However, 4 (80%) of
5 newly diagnosed and 23 (32%) of 73 established Type 1 DM patients w
ith abnormalities in heart rate variation during deep breathing and/or
standing from lying presented with CF-SG autoantibodies compared to 1
2 (25%) of 58 newly diagnosed (p < 0.05) and 7 (11%) of 63 established
Type 1 DM patients (p < 0.01), in whom both tests were normal. The re
sults suggest that autoimmune factors contribute to the pathogenesis o
f cardiac autonomic dysfunction in Type 1 DM and that autoantibodies a
gainst sympathetic and parasympathetic nervous tissues are relatively
specific for Type 1 DM. (C) 1998 John Wiley & Sons, Ltd.